Clinical Trials Sponsored by Parker Hughes Cancer Center
Total 1898 results
-
Parker Hughes Cancer CenterUnknownLymphoma | LeukemiaUnited States
-
The Dale & Frances Hughes Cancer CenterMedImmune LLCCompletedHead and Neck Cancer | Lung CancerUnited States
-
Jonsson Comprehensive Cancer CenterParker Institute for Cancer ImmunotherapyRecruitingRecurrent Mantle Cell Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Chronic Lymphocytic Leukemia | CD20 Positive | Refractory Mantle Cell Lymphoma | Recurrent Chronic Lymphocytic Leukemia | Refractory... and other conditionsUnited States
-
Rocky Mountain Cancer CentersDr. Dennis CarterWithdrawn
-
Emory UniversityThe Carter CenterSuspended
-
M.D. Anderson Cancer CenterDana-Farber Cancer InstituteActive, not recruitingHead and Neck Squamous Cell CarcinomaUnited States
-
Dana-Farber Cancer InstituteKaryopharm Therapeutics Inc; William Lawrence and Blanche Hughes FoundationActive, not recruitingRelapsed Acute Lymphoblastic Leukemia (ALL) | Refractory Acute Lymphoblastic Leukemia (ALL) | Relapsed Acute Myelogenous Leukemia (AML) | Refractory Acute Myelogenous Leukemia (AML) | Relapsed Mixed Lineage Leukemia | Refractory Mixed Lineage Leukemia | Relapsed Biphenotypic Leukemia | Refractory... and other conditionsUnited States
-
Dana-Farber Cancer InstitutePartner Therapeutics (PTx)WithdrawnMetastatic Melanoma | Unresectable Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer InstituteActive, not recruitingProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Novartis; Dana-Farber Cancer InstituteCompletedNeuroendocrine TumorsUnited States
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute:Dana- Farber/Children's HospitalActive, not recruitingRelapsed B-Cell Acute Lymphoblastic LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; Marker Therapeutics, Inc.Completed
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Jonsson Comprehensive Cancer CenterCompleted
-
University of Texas Southwestern Medical CenterNational Cancer Institute (NCI); Howard Hughes Medical InstituteRecruitingKidney Cancer | Renal Cell Carcinoma | Urothelial Carcinoma | Hereditary Leiomyomatosis and Renal Cell Cancer | Metastatic Urothelial Carcinoma | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | HLRCC | Clear Cell Carcinoma | Metastatic Kidney Cancer | Fumarate Hydratase Deficiency | Succinate...United States
-
Dartmouth-Hitchcock Medical CenterM.D. Anderson Cancer Center; Dana-Farber Cancer Institute; AstraZeneca; Kentuckiana...CompletedNonresectable Adrenocortical CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Northwestern University; Dana-Farber Cancer Institute and other collaboratorsCompletedBronchioloalveolar Cell Variant of Non-small Cell Lung CancerUnited States
-
Massachusetts General HospitalM.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Dana-Farber...CompletedNon Small Cell Lung CancerUnited States
-
Hackensack Meridian HealthM.D. Anderson Cancer Center; Iscador AG, Arlesheim, Switzerland.; Tackle Kids... and other collaboratorsRecruitingOsteogenic Sarcoma RecurrentUnited States
-
Huabo Biopharm Co., Ltd.M.D. Anderson Cancer Center; Dana-Farber Cancer Institute; Gabrail Cancer Center...Not yet recruiting
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Dana-Farber Cancer Institute; University of PittsburghCompletedAdvanced Gastrointestinal Stromal Tumor (GIST)United States
-
University of Michigan Rogel Cancer CenterDana-Farber Cancer Institute; Vanderbilt University Medical CenterActive, not recruitingBiliary Tract CancerUnited States
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLC; Parker Institute for Cancer ImmunotherapyRecruitingAdvanced SarcomaUnited States
-
Alison WalkerCompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute; Stanford UniversityActive, not recruitingLymphoma | Relapsed/Refractory T-cell LymphomasUnited States
-
Dana-Farber/Brigham and Women's Cancer CenterNational Cancer Institute (NCI)UnknownPrecancerous ConditionUnited States
-
Memorial Sloan Kettering Cancer CenterYale University; Dana-Farber Cancer InstituteActive, not recruitingLeukemia | Leukemia, Hairy Cell | Hairy Cell LeukemiaUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Boston Medical CenterCompleted
-
Piramal Enterprises LimitedDana-Farber Cancer Institute; Norris Cotton Cancer CenterSuspendedRelapsed/Refractory Chronic Lymphocytic Leukemia (CLL)United States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Dana-Farber Cancer InstituteCompletedSarcoma | Small Intestine Cancer | Ovarian Cancer | Endometrial Cancer | Desmoid Tumor | Adult Malignant Fibrous Histiocytoma of BoneUnited States
-
Shanghai Huaota Biopharmaceutical Co., Ltd.M.D. Anderson Cancer Center; Dana-Farber Cancer Institute; Gabrail Cancer Center...Recruiting
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); GlaxoSmithKline; Dana-Farber Cancer InstituteCompleted
-
Beth Israel Deaconess Medical CenterCompletedOvarian Cancer | Peritoneal Cavity CancerUnited States
-
AbbottM.D. Anderson Cancer Center; Dana-Farber Cancer Institute; Norwood Immunology...TerminatedLymphoma, Non-Hodgkin | Multiple Myeloma | Hodgkin Disease | Mantle Cell LymphomaUnited States
-
Tel-Aviv Sourasky Medical CenterDana-Farber Cancer InstituteRecruiting
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteRecruitingProstate Cancer | Prostate Adenocarcinoma | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)United States
-
Beth Israel Deaconess Medical CenterRecruitingRenal Cell CarcinomaUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteActive, not recruitingRecurrent Adult Acute Myeloid Leukemia | Acute Myeloid Leukemia, in RelapseUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteCompletedMalignant MelanomaUnited States
-
Beth Israel Deaconess Medical CenterActive, not recruiting
-
Beth Israel Deaconess Medical CenterTerminated
-
Beth Israel Deaconess Medical CenterWithdrawnRenal Cell CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute; Chugai Pharma USAActive, not recruitingAdvanced Non-small Cell Lung CancerUnited States
-
AHS Cancer Control AlbertaTom Baker Cancer CentreRecruitingGlioblastoma | Recurrent Glioblastoma | Recurrent DiseaseCanada
-
AHS Cancer Control AlbertaTom Baker Cancer CentreActive, not recruitingCarcinoma of Unknown PrimaryCanada
-
AHS Cancer Control AlbertaTom Baker Cancer CentreWithdrawnMetastatic Triple Negative Breast CancerCanada
-
AHS Cancer Control AlbertaTom Baker Cancer CentreRecruitingBreast Cancer | Colorectal CancerCanada
-
AHS Cancer Control AlbertaTom Baker Cancer CentreRecruitingMyeloma | Myeloma MultipleCanada
-
AHS Cancer Control AlbertaTom Baker Cancer CentreTerminatedFollicular Lymphoma | Hodgkin's Lymphoma - Relapsed/Refractory | Non-Hodgkin's Lymphoma - AggressiveCanada
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteTerminatedBreast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Node-negative Breast CancerUnited States
-
Beth Israel Deaconess Medical CenterWithdrawn